相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Marco Del Chiaro et al.
ANNALS OF SURGERY (2020)
Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms
Hiroki Oyama et al.
GASTROENTEROLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms
Gabriele Capurso et al.
JAMA NETWORK OPEN (2020)
Endoscopic diagnosis of cystic lesions of the pancreas
Ken Kamata et al.
DIGESTIVE ENDOSCOPY (2019)
Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review
Yingying Mao et al.
BMC CANCER (2019)
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers
Aatur D. Singhi et al.
GASTROENTEROLOGY (2019)
Evaluation of efficacy of pancreatic juice cytology for risk classification according to international consensus guidelines in patients with intraductal papillary mucinous neoplasm; a retrospective study
Kohei Yamakawa et al.
PANCREATOLOGY (2019)
Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations
Catherine G. Fischer et al.
GASTROENTEROLOGY (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Trivial Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
Giovanni Marchegiani et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines
Nadine C. M. van Huijgevoort et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features
Yuko Omori et al.
GASTROENTEROLOGY (2019)
Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms
Tsuyoshi Hamada et al.
JOURNAL OF PATHOLOGY (2019)
Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues
Mingfeng Zhang et al.
GUT (2018)
Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia
Aatur D. Singhi et al.
GUT (2018)
Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study
Samuel O. Antwi et al.
CARCINOGENESIS (2018)
Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size
Youngmin Han et al.
GASTROENTEROLOGY (2018)
IPMNs with co-occurring invasive cancers: neighbours but not always relatives
Matthaus Felsenstein et al.
GUT (2018)
European evidence-based guidelines on pancreatic cystic neoplasms
Marco Del Chiaro et al.
GUT (2018)
Gastroduodenal Ulcers and ABO Blood Group: the Japan Nurses' Health Study (JNHS)
Lobna Alkebsi et al.
JOURNAL OF EPIDEMIOLOGY (2018)
Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology
Shuji Ogino et al.
Annual Review of Pathology-Mechanisms of Disease (2018)
From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions
Catherine G. Fischer et al.
JOURNAL OF PATHOLOGY (2018)
Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms
Saurabh Mukewar et al.
GUT (2017)
Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center
Ilaria Pergolini et al.
GASTROENTEROLOGY (2017)
Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas
Masao Tanaka et al.
PANCREATOLOGY (2017)
Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm
Krushna C. Patra et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
Statistical methods for studying disease subtype heterogeneity
Molin Wang et al.
STATISTICS IN MEDICINE (2016)
The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms
V. Raman Muthusamy et al.
GASTROINTESTINAL ENDOSCOPY (2016)
Pancreatic Cancer Genetics
Laufey T. Amundadottir
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Development of Pancreatic Cancer, Disease-specific Mortality, and All-Cause Mortality in Patients with Nonresected IPMNs: A Long-term Cohort Study
Naoyoshi Nagata et al.
RADIOLOGY (2016)
The role of the histoblood ABO group in cancer
Seth K. Rummel et al.
FUTURE SCIENCE OA (2016)
PSHREG: A SAS macro for proportional and nonproportional subdistribution hazards regression
Maria Kohl et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2015)
American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts
Santhi Swaroop Vege et al.
GASTROENTEROLOGY (2015)
Disease-Specific Mortality Among Patients With Intraductal Papillary Mucinous Neoplasm of the Pancreas
Kazumichi Kawakubo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Estimation and comparison of cumulative incidences of biliary self- expandable metallic stent dysfunction accounting for competing risks
Tsuyoshi Hamada et al.
DIGESTIVE ENDOSCOPY (2014)
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
Brian M. Wolpin et al.
NATURE GENETICS (2014)
ABO Blood Group and Risk of Pancreatic Cancer: A Study in Shanghai and Meta-Analysis
Harvey A. Risch et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A and B Blood Group Antigens in Human Pancreatic Ductal Adenocarcinomas
Adriana Handra-Luca
ONCOLOGY (2013)
An Absolute Risk Model to Identify Individuals at Elevated Risk for Pancreatic Cancer in the General Population
Alison P. Klein et al.
PLOS ONE (2013)
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Masao Tanaka et al.
PANCREATOLOGY (2012)
ABO Research in the Modern Era of Genomics
Fumiichiro Yamamoto et al.
TRANSFUSION MEDICINE REVIEWS (2012)
ABO blood group alleles and the risk of pancreatic cancer in a Japanese population
Makoto Nakao et al.
CANCER SCIENCE (2011)
Incidence of extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasms of the pancreas
Kazumichi Kawakubo et al.
GUT (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Variant ABO Blood Group Alleles, Secretor Status, and Risk of Pancreatic Cancer: Results from the Pancreatic Cancer Cohort Consortium
Brian M. Wolpin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Pancreatic Cancer Risk and ABO Blood Group Alleles: Results from the Pancreatic Cancer Cohort Consortium
Brian M. Wolpin et al.
CANCER RESEARCH (2010)
ABO Blood Group and the Risk of Pancreatic Cancer
Brian M. Wolpin et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
Laufey Amundadottir et al.
NATURE GENETICS (2009)
International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas
Masao Tanaka et al.
PANCREATOLOGY (2006)
分享论文
